Overview

Dose Finding Study of STR-324

Status:
Recruiting
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate the analgesic effect and the safety of 4 doses of STR-324 administered as an infusion, with or without initial bolus, to patients suffering from post-operative pain. The sensitivity of the pain model used in the trial will be evaluated with a standard group treated with morphine under the usual care conditions.
Phase:
Phase 2
Details
Lead Sponsor:
Alaxia SAS
Stragen France
Treatments:
Morphine